Fust Matthew K Insider Trading
Get the latest insider transactions of Fust Matthew K. Fust Matthew K is EVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and EVP, Chief Financial Officer in Jazz Pharmaceuticals plc ($JAZZ) and Senior Vice President & CFO in Jazz Pharmaceuticals plc ($JAZZ) and SVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and Director in MACROGENICS INC ($MGNX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and in Dermira, Inc. ($DERM) and Director in Dermira, Inc. ($DERM) and Director in Atara Biotherapeutics, Inc. ($ATRA) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX). Discover the current value of Fust Matthew K shares.
Address: C/O JAZZ PHARMACEUTICALS, INC. 3180 PORTER DRIVE PALO ALTO 94304CA
Fust Matthew K is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals plc | EVP, Chief Financial Officer, EVP and CFO, SVP and CFO, Senior Vice President & CFO | 58,948 | 7,371,447.40 |
RARE | Ultragenyx Pharmaceutical Inc. | Director | 19,731 | 1,438,587.21 |
ATRA | Atara Biotherapeutics, Inc. | Director | 33,854 | 509,502.70 |
MGNX | MACROGENICS INC | Director | 7,424 | 138,309.12 |
DERM | Dermira, Inc. | 0 | 0.00 | |
CRNX | Crinetics Pharmaceuticals, Inc. | Director | 16,036 |
Insider Trading Transactions of Fust Matthew K
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jul 08 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 21.00 | 6,181 | 129,801 | 19,731 |
Jul 08 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Sell | 90.00 | 6,181 | 556,290 | 13,550 |
Jul 08 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 21.00 | 6,181 | 129,801 | 0 |
Jul 06 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 21.00 | 5,000 | 105,000 | 18,550 |
Jul 06 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Sell | 85.00 | 5,000 | 425,000 | 13,550 |
Jul 06 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 21.00 | 5,000 | 105,000 | 6,181 |
Jun 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 0.00 | 2,550 | 0 | 13,550 |
Jun 30 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 76.58 | 4,250 | 325,465 | 4,250 |
Jun 22 2020 | CRNX | Crinetics Pharmaceuticals ... | Fust Matthew K | Director | Option Exercise | 23.23 | 12,500 | 290,375 | 12,500 |
Jun 17 2020 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 8,000 | 0 | 33,854 |
Jun 17 2020 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 10.54 | 24,500 | 258,230 | 24,500 |
May 19 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Sell | 75.00 | 1,875 | 140,625 | 11,000 |
Apr 24 2020 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Sell | 65.00 | 1,875 | 121,875 | 12,875 |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Sell | 18.75 | 5,051 | 94,706 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 5.51 | 14,224 | 78,374 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 16.00 | 10,344 | 165,504 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 28.82 | 10,344 | 298,114 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 28.01 | 6,000 | 168,060 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 9.95 | 6,000 | 59,700 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 9.38 | 6,000 | 56,280 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 0.00 | 3,000 | 0 | 0 | |
Dec 26 2019 | DERM | Dermira, Inc. | Fust Matthew K | Sell | 15.00 | 3,000 | 45,000 | 5,051 | |
Dec 18 2019 | CRNX | Crinetics Pharmaceuticals ... | Fust Matthew K | Director | Buy | 1.91 | 3,500 | 6,685 | 16,036 |
Dec 18 2019 | CRNX | Crinetics Pharmaceuticals ... | Fust Matthew K | Director | Sell | 22.50 | 3,500 | 78,750 | 12,536 |
Dec 18 2019 | CRNX | Crinetics Pharmaceuticals ... | Fust Matthew K | Director | Option Exercise | 1.91 | 3,500 | 6,685 | 42,092 |
Dec 13 2019 | DERM | Dermira, Inc. | Fust Matthew K | Sell | 12.00 | 3,000 | 36,000 | 8,051 | |
Sep 16 2019 | DERM | Dermira, Inc. | Fust Matthew K | Sell | 8.77 | 6,000 | 52,636 | 11,051 | |
Jul 01 2019 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 4,000 | 0 | 25,854 |
Jul 01 2019 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 20.25 | 13,000 | 263,250 | 13,000 |
Jun 25 2019 | CRNX | Crinetics Pharmaceuticals ... | Fust Matthew K | Director | Option Exercise | 23.24 | 12,500 | 290,500 | 12,500 |
Jun 14 2019 | DERM | Dermira, Inc. | Fust Matthew K | Buy | 0.00 | 3,000 | 0 | 17,051 | |
Jun 14 2019 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 0.00 | 3,000 | 0 | 0 | |
Jun 13 2019 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 0.00 | 3,000 | 0 | 14,750 |
Jun 13 2019 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 58.74 | 5,000 | 293,700 | 5,000 |
Jun 06 2019 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 9.38 | 6,000 | 56,280 | 6,000 | |
Jun 06 2019 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 0.00 | 3,000 | 0 | 3,000 | |
May 20 2019 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | 18.00 | 10,000 | 180,000 | 10,000 |
Feb 08 2019 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Buy | 20.15 | 6,924 | 139,519 | 7,424 |
Feb 08 2019 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Sell | 29.38 | 6,924 | 203,427 | 500 |
Feb 08 2019 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | 20.15 | 6,924 | 139,519 | 0 |
Oct 19 2018 | DERM | Dermira, Inc. | Fust Matthew K | Sell | 13.75 | 4,000 | 55,000 | 14,051 | |
Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 0.00 | 3,000 | 0 | 11,750 |
Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 80.69 | 5,000 | 403,450 | 5,000 |
Jun 18 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,500 | 0 | 21,854 |
Jun 18 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 45.65 | 5,000 | 228,250 | 5,000 |
Jun 14 2018 | DERM | Dermira, Inc. | Fust Matthew K | Buy | 0.00 | 3,000 | 0 | 18,051 | |
Jun 14 2018 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 9.95 | 6,000 | 59,700 | 6,000 | |
Jun 14 2018 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 0.00 | 3,000 | 0 | 3,000 | |
Jun 14 2018 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 0.00 | 3,000 | 0 | 0 | |
May 30 2018 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Sell | 72.00 | 6,319 | 454,969 | 8,750 |
May 21 2018 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | 21.34 | 10,000 | 213,400 | 10,000 |
May 16 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Sell | 43.57 | 12,286 | 535,301 | 19,820 |
May 16 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 534 | 0 | 20,354 |
May 16 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 534 | 0 | 0 |
Feb 20 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,603 | 0 | 32,106 |
Feb 20 2018 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,603 | 0 | 534 |
Nov 17 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,602 | 0 | 30,503 |
Nov 17 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,602 | 0 | 2,137 |
Aug 17 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,603 | 0 | 28,901 |
Aug 17 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,603 | 0 | 3,739 |
Jun 22 2017 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 0.00 | 1,875 | 0 | 15,069 |
Jun 22 2017 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 65.66 | 3,750 | 246,225 | 3,750 |
Jun 15 2017 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 28.01 | 6,000 | 168,060 | 6,000 | |
Jun 15 2017 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 0.00 | 3,000 | 0 | 3,000 | |
Jun 12 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 5,000 | 0 | 27,298 |
Jun 12 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 13.20 | 21,500 | 283,800 | 21,500 |
May 22 2017 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | 19.57 | 10,000 | 195,700 | 10,000 |
Feb 16 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,603 | 0 | 20,696 |
Feb 16 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,603 | 0 | 6,944 |
Jan 05 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 2,000 | 0 | 19,093 |
Jan 05 2017 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 15.08 | 5,500 | 82,940 | 5,500 |
Nov 17 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,602 | 0 | 17,093 |
Nov 17 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,602 | 0 | 8,547 |
Aug 17 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,603 | 0 | 15,491 |
Aug 17 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,603 | 0 | 10,149 |
Jun 23 2016 | DERM | Dermira, Inc. | Fust Matthew K | Option Exercise | 28.82 | 10,344 | 298,114 | 10,344 | |
Jun 14 2016 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Buy | 0.00 | 1,875 | 0 | 13,194 | |
Jun 14 2016 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Option Exercise | 65.85 | 3,750 | 246,938 | 3,750 | |
May 20 2016 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | 21.06 | 8,500 | 179,010 | 8,500 |
May 18 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,602 | 0 | 13,888 |
May 18 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,602 | 0 | 11,752 |
Feb 18 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,603 | 0 | 12,286 |
Feb 18 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,603 | 0 | 13,354 |
Jan 05 2016 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 24.05 | 10,500 | 252,525 | 10,500 |
Nov 18 2015 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,602 | 0 | 10,683 |
Nov 18 2015 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,602 | 0 | 14,957 |
Aug 19 2015 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 1,603 | 0 | 9,081 |
Aug 19 2015 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 1,603 | 0 | 16,559 |
Jun 30 2015 | DERM | Dermira, Inc. | Fust Matthew K | Director | Buy | 5.51 | 9,051 | 49,871 | 15,051 |
Jun 30 2015 | DERM | Dermira, Inc. | Fust Matthew K | Director | Option Exercise | 5.51 | 9,051 | 49,871 | 14,224 |
Jun 22 2015 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Option Exercise | 97.85 | 7,500 | 733,875 | 7,500 | |
Jun 15 2015 | DERM | Dermira, Inc. | Fust Matthew K | Director | Option Exercise | 16.00 | 10,344 | 165,504 | 10,344 |
May 21 2015 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | 32.34 | 8,500 | 274,890 | 8,500 |
May 19 2015 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Buy | 0.00 | 7,478 | 0 | 7,478 |
May 19 2015 | ATRA | Atara Biotherapeutics, In ... | Fust Matthew K | Director | Option Exercise | 0.00 | 7,478 | 0 | 18,162 |
Mar 23 2015 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Buy | 21.00 | 6,319 | 132,699 | 11,319 |
Mar 23 2015 | RARE | Ultragenyx Pharmaceutical ... | Fust Matthew K | Director | Option Exercise | 21.00 | 6,319 | 132,699 | 11,181 |
Dec 01 2008 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | EVP, Chief Financial ... | Buy | 1.28 | 379 | 485 | 58,948 |
Jun 02 2008 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | EVP and CFO | Buy | 6.50 | 1,203 | 7,820 | 58,569 |
May 19 2008 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | EVP and CFO | Buy | 0.00 | 6,281 | 0 | 57,366 |
May 19 2008 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | EVP and CFO | Option Exercise | 7.96 | 60,000 | 477,600 | 60,000 |
Dec 03 2007 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | SVP and CFO | Buy | 13.18 | 1,388 | 18,294 | 51,085 |
Jun 06 2007 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | Senior Vice President ... | Buy | 0.00 | 19,879 | 0 | 49,697 |
Jun 06 2007 | JAZZ | Jazz Pharmaceuticals plc | Fust Matthew K | Senior Vice President ... | Option Exercise | 0.00 | 19,879 | 0 | 0 |